Comparison Efficacy in Patients With Asthma Using Foster MDI and Relvar Medications

• Status: Enrolling by invitation
• Trial end date: 2022-06-30
• Target enrollment: 0
• Participant gender: All

Summary

This is a randomized study to compare asthma patients using Foster or Relvar.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Far Eastern Memorial Hospital
• Collaborator: Orient Europharma Co., Ltd.

Criteria

Inclusion Criteria:

• patients diagnosis with asthma with treatment naive

• asthma patients with poor controlled status

Exclusion Criteria:

• COPD

• smoking history

• pregnancy

• cardiaovascular disease

• patients with acute respiratory infection